Neoantigens expressed in ovarian cancer and their uses | Patent Number 11945881

US 11945881 B2
Application Number17174505
Publication NumberUS 20210261609 A1
Pendency3 years, 1 month, 20 days
Filled DateFeb 12, 2021
Priority Date-
Publication DateAug 26, 2021
Expiration DateFeb 11, 2041
Inventor/ApplicantsManuel Alejandro Sepulveda
Vinod Krishna
David J. Pocalyko
Vipul BHARGAVA
Pegah Safabakhsh
Vipul Bhargava
ExaminesPOPA, ILEANA
Art Unit1633
Technology Center1600
Assignments
Janssen Biotech Inc.
Current
Janssen Biotech Inc.Johnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.